Recombinant Callicebus moloch Ubiquitin-like protein 4A (UBL4A)

Shipped with Ice Packs
In Stock

Description

Structure and Functional Domains

UBL4A belongs to the ubiquitin-like protein family, characterized by a conserved ubiquitin-like (UBL) domain. Key features include:

DomainFunctionConservation
N-terminal UBLProtein-protein interactions85% across primates
Central α-helixStructural stabilization92% in placental mammals
C-terminal motifSubcellular localization signalsSpecies-specific variations

Human UBL4A is 157 amino acids long with a molecular weight of ~17 kDa . While Callicebus moloch UBL4A remains unsequenced, its homologs participate in autophagy regulation and ER-associated protein sorting .

Biological Roles

UBL4A functions as:

  • Autophagy inhibitor: Blocks late-stage autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma .

  • Chaperone mediator: Partners with BAG6/BAT3 to direct tail-anchored proteins to the ER membrane .

  • Tumor suppressor: Downregulation correlates with poor prognosis in cancers .

Studies in Caenorhabditis elegans (UBL-5 homolog) reveal roles in mitochondrial unfolded protein response and spliceosomal activity , though these functions remain unconfirmed in primates.

Recombinant Production Challenges

No experimental protocols for Callicebus moloch UBL4A exist, but human UBL4A production methods provide guidance:

ParameterHuman UBL4A ProtocolChallenges for Non-Model Species
Expression systemE. coli BL21(DE3)Codon optimization required
PurificationNi-NTA affinity chromatographyAntibody cross-reactivity untested
Yield5–10 mg/L cultureLower yields expected

Research Gaps and Opportunities

  • Evolutionary divergence: Callicebus moloch UBL4A may exhibit unique motifs compared to human or rodent homologs .

  • Functional assays: Autophagy modulation and spliceosomal roles observed in yeast/C. elegans need validation in primates.

  • Therapeutic potential: Human UBL4A’s tumor-suppressive activity suggests analogous applications if conserved.

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us.
Synonyms
UBL4A; Ubiquitin-like protein 4A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-157
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Plecturocebus moloch (Dusky titi monkey) (Callicebus moloch)
Target Names
UBL4A
Target Protein Sequence
MQLTVKALQG RECSLQVPED ELVSTLKQLV SEKLNVPVRQ QRLLFKGKAL ADGKRLSDYS IGPNSKLNLV VKPLEKVLLE EGAGRRLADS PPTQVWQLIS KVLARHFSAA DASRVLEQLQ RDYQRSLSRL TLDDIERLAS RFLHPEVTET MEKGFSK
Uniprot No.

Target Background

Function
The BAG6/BAT3 complex, a cytosolic protein quality control system, maintains misfolded and hydrophobic proteins in a soluble state and directs them to the endoplasmic reticulum or the proteasome for degradation. It aids post-translational delivery of tail-anchored proteins to the ER membrane by interacting with their transmembrane regions and mediating delivery with SGTA and ASNA1. Proteins failing ER delivery are ubiquitinated and sent to the proteasome. The complex also sorts mislocalized secretory pathway proteins for degradation or ER delivery. It participates in ER-associated degradation (ERAD) by maintaining retrotranslocated proteins in a soluble state for proteasomal delivery.
Subcellular Location
Cytoplasm, cytosol. Nucleus.

Q&A

What is Callicebus moloch UBL4A and what are its primary functions in cellular processes?

Callicebus moloch UBL4A is an X-linked ubiquitin-like protein found in dusky titi monkeys (Callicebus moloch), which belongs to the Pitheciidae family . In mammals, UBL4A serves as a housekeeping gene that is ubiquitously expressed across different tissues . Functionally, UBL4A plays significant roles in:

  • Protein metabolism and maintenance of cellular homeostasis

  • Positive regulation of NF-κB signaling in immune cells, particularly dendritic cells and macrophages

  • Antitumor activity through modulation of autophagy-related proliferation and metastasis by directly targeting LAMP1

  • Forming critical protein complexes with Bag6 and SGTA co-chaperones

Research methodologies to study these functions typically involve gene knockout models, co-immunoprecipitation assays, and protein interaction studies to elucidate the protein's role in various cellular pathways.

How is UBL4A protein structured and which domains are critical for its function?

UBL4A contains specific structural elements that determine its functional properties:

  • N-terminal ubiquitin-like (UBL) domain that interacts with the Bag6 co-chaperone SGTA

  • C-terminal segment that binds to Bag6

  • The C-terminus contains two regular helices (H1 and H2) and a short half-helix (H3)

  • H1 and H2 collectively form a concave structure that interacts with Bag6

  • The binding interface is decorated by several hydrophobic residues from H1 and H2

When investigating these domains, researchers should employ structural biology techniques including X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to determine precise interaction interfaces. Site-directed mutagenesis of key residues can help validate the functional importance of specific domains.

What evolutionary patterns are observed in UBL4A genes across primate species?

Phylogenetic analyses reveal important evolutionary patterns in UBL4A:

  • UBL4A genes are detected across vertebrates including fishes, amphibians, reptiles, birds, and mammals

  • UBL4A has undergone purifying selection in mammals, with an ω value of 0.07033 (p=0.00067), indicating strong conservation of function

  • Approximately half of UBL4A genes are located on X chromosomes with four exons

  • UBL4A likely shares a common ancestral gene with UBL4B

  • UBL4B is present only in reptiles and mammals and evolved through retroposition that occurred at least 170 million years ago

For studying evolutionary relationships, researchers should employ molecular phylogenetic methods including maximum likelihood and Bayesian inference approaches to analyze both nuclear and mitochondrial genetic markers.

What expression systems are recommended for producing recombinant Callicebus moloch UBL4A?

Based on the structural and functional properties of UBL4A, researchers should consider:

  • Bacterial expression systems (E. coli) for basic structural studies, using vectors containing N-terminal tags (His6 or GST) to prevent interference with the C-terminal Bag6 binding region

  • Mammalian expression systems (HEK293 or CHO cells) for functional studies where post-translational modifications may be important

  • Baculovirus expression systems for large-scale production of properly folded protein

The choice of expression system should be guided by the specific research question, with consideration of protein solubility, proper folding, and potential requirement for post-translational modifications.

How does UBL4A degradation occur when not assembled with its binding partners?

Unassembled UBL4A undergoes regulated degradation through specific mechanisms:

  • Degradation occurs via the ubiquitin-proteasome system rather than lysosomal pathways

  • MG132 (proteasome inhibitor) treatment increases UBL4A levels in Bag6-null cells

  • The degradation signal resides in the hydrophobic residue-containing segment normally embedded when UBL4A forms a complex with Bag6

  • Specifically, helix H1 contains the primary destabilizing element

  • HUWE1 has been identified as a ubiquitin ligase responsible for targeting unassembled UBL4A

  • This degradation does not involve the N-end rule pathway, as knockdown of UBR1, UBR2, UBR3, RNF126, and CNOT4 had no effect on UBL4A stability

This represents a novel protein quality control (PQC) mechanism for regulating unassembled soluble proteins, distinct from previously characterized pathways.

What are the functional consequences of UBL4A and UBL4B knockout in experimental models?

Knockout studies provide unexpected insights into UBL4A/B function:

  • UBL4A knockout mice are viable with no obvious abnormalities in development and growth during 6 months after birth

  • UBL4B knockout mice (UBL4B^-/-) showed normal fertility and spermatogenesis

  • Double knockout mice lacking both UBL4A and UBL4B (UBL4A^-/Y; UBL4B^-/-) also display normal spermatogenesis

  • These findings suggest that both UBL4A and UBL4B are dispensable for spermatogenesis in vivo

  • This provides evidence that some X chromosome-derived autosomal retrogenes may be nonfunctional in spermatogenesis

These surprising results highlight the importance of empirical testing rather than assumption-based approaches when studying gene function, particularly for genes believed to be essential based on evolutionary conservation.

What methodologies are most effective for studying UBL4A's role in NF-κB signaling pathways?

To investigate UBL4A's role in NF-κB signaling, researchers should employ:

  • Dendritic cell and macrophage models where UBL4A has been shown to maintain innate immune responses

  • CRISPR/Cas9-mediated gene editing to create cellular models with UBL4A modifications

  • Luciferase reporter assays using NF-κB response elements to measure pathway activation

  • Co-immunoprecipitation experiments to identify direct UBL4A interactors in the signaling cascade

  • Phosphorylation-specific antibodies to track activation states of pathway components

  • RNA-seq or proteomics approaches to assess global changes in gene expression following UBL4A manipulation

When designing these experiments, researchers should include appropriate controls and consider the cell type-specific effects of UBL4A modulation.

How can comparative genomics inform our understanding of UBL4A function across the Callicebus genus?

The Callicebus genus offers a valuable opportunity for comparative genomics approaches:

  • The genus comprises 34 recognized species arranged in five groups: C. moloch, C. cupreus, C. donacophilus, C. torquatus, and C. personatus

  • Molecular phylogenetic analysis using nuclear markers (Alu insertions and flanking regions) and mitochondrial genes (16S, COI, and Cyt b) provides insight into evolutionary relationships

  • Recent evidence suggests the C. cupreus group should be reintegrated into the C. moloch group

  • Comparative genomics can reveal species-specific adaptations in UBL4A structure and function

Researchers should sequence and annotate UBL4A genes across multiple Callicebus species, performing both synteny and expression analyses to identify conserved regulatory elements and species-specific variations.

What are the challenges in purifying recombinant Callicebus moloch UBL4A and how can they be addressed?

Recombinant UBL4A purification presents several challenges:

  • Tendency for unassembled UBL4A to be targeted for degradation by HUWE1 and the proteasome

  • Potential for aggregation due to exposed hydrophobic interfaces normally embedded in protein complexes

  • Need to maintain proper folding of both the N-terminal UBL domain and C-terminal helices

Recommended approaches include:

  • Co-expression with binding partners (Bag6, SGTA) to stabilize the protein

  • Addition of proteasome inhibitors during early purification steps

  • Use of detergents or stabilizing agents to prevent aggregation

  • Limited proteolysis approaches to identify stable domains for structural studies

  • Size exclusion chromatography to ensure homogeneous, non-aggregated samples

How can researchers validate antibodies for specific detection of Callicebus moloch UBL4A versus other primate homologs?

Antibody validation is critical for species-specific UBL4A detection:

  • Recombinant expression of UBL4A from multiple primate species for side-by-side comparison

  • Western blot analysis using tissues from UBL4A knockout models as negative controls

  • Peptide competition assays using synthesized peptides representing species-specific regions

  • Immunoprecipitation followed by mass spectrometry to confirm specificity

  • Immunohistochemistry with appropriate positive and negative controls

Researchers should focus validation efforts on antibodies targeting regions that show sequence divergence between Callicebus moloch and other primates to ensure specificity.

What insights from Callicebus moloch UBL4A studies might be relevant to human disease models?

UBL4A research in Callicebus moloch can inform human disease studies:

  • Understanding the role of UBL4A in maintaining innate immune responses through NF-κB signaling has implications for inflammatory and autoimmune conditions

  • The antitumor role of UBL4A in regulating autophagy-related proliferation and metastasis in pancreatic ductal adenocarcinoma suggests potential therapeutic applications

  • Protein quality control mechanisms involving UBL4A may be relevant to neurodegenerative diseases characterized by protein misfolding

  • Comparative analysis between Callicebus and human UBL4A can reveal evolutionarily conserved functional domains critical for therapeutic targeting

Researchers should employ comparative functional assays to determine which aspects of UBL4A biology are conserved between Callicebus moloch and humans.

How might the evolutionary relationship between UBL4A and UBL4B inform research on X-chromosome inactivation patterns?

The UBL4A/UBL4B relationship provides a model for studying sex chromosome evolution:

This system provides an excellent model for studying the evolutionary dynamics of X-linked genes and their autosomal counterparts.

What emerging technologies might advance our understanding of UBL4A's role in protein quality control mechanisms?

Several cutting-edge approaches show promise for UBL4A research:

  • Proximity labeling techniques (BioID, APEX) to identify the complete interactome of UBL4A in different cellular compartments

  • Cryo-electron microscopy to visualize UBL4A in complex with Bag6 and other binding partners

  • Single-molecule FRET to study conformational changes upon complex formation

  • CRISPR screens to identify genetic modifiers of UBL4A function

  • Optical tweezers or atomic force microscopy to measure binding forces between UBL4A and its partners

These technologies will help elucidate the dynamic interactions and conformational changes that underlie UBL4A's functions in protein quality control.

How can comparative analysis of UBL4A across the Callicebus genus inform primate taxonomy and evolution?

The study of UBL4A across Callicebus species can contribute to taxonomic understanding:

  • Given the disagreements about the composition of the C. moloch group, molecular analysis of UBL4A can provide additional evidence for taxonomic classification

  • Considering that UBL4A is under purifying selection, the rate of sequence divergence can serve as a molecular clock for estimating divergence times

  • Integration of UBL4A sequence data with other molecular markers can help resolve phylogenetic relationships within the genus

  • Analysis of UBL4A expression patterns across different Callicebus species may reveal tissue-specific adaptations

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.